These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 10998420
1. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML, Brown S, Mobashery S, Fridman R. J Biol Chem; 2000 Dec 29; 275(52):41415-23. PubMed ID: 10998420 [Abstract] [Full Text] [Related]
5. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R. J Biol Chem; 2000 Apr 21; 275(16):12080-9. PubMed ID: 10766841 [Abstract] [Full Text] [Related]
6. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM. Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829 [Abstract] [Full Text] [Related]
7. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. Maquoi E, Frankenne F, Baramova E, Munaut C, Sounni NE, Remacle A, Noël A, Murphy G, Foidart JM. J Biol Chem; 2000 Apr 14; 275(15):11368-78. PubMed ID: 10753951 [Abstract] [Full Text] [Related]
8. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA, Fridman R. Biochem Biophys Res Commun; 2001 Feb 16; 281(1):126-30. PubMed ID: 11178970 [Abstract] [Full Text] [Related]
9. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V. Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911 [Abstract] [Full Text] [Related]
10. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y. J Pathol; 2004 Apr 15; 202(4):403-11. PubMed ID: 15095267 [Abstract] [Full Text] [Related]
12. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation. Overall CM, Tam E, McQuibban GA, Morrison C, Wallon UM, Bigg HF, King AE, Roberts CR. J Biol Chem; 2000 Dec 15; 275(50):39497-506. PubMed ID: 10991943 [Abstract] [Full Text] [Related]
13. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. Shofuda K, Moriyama K, Nishihashi A, Higashi S, Mizushima H, Yasumitsu H, Miki K, Sato H, Seiki M, Miyazaki K. J Biochem; 1998 Aug 15; 124(2):462-70. PubMed ID: 9685743 [Abstract] [Full Text] [Related]
14. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, Sato H. J Biol Chem; 2001 Jul 27; 276(30):28204-11. PubMed ID: 11382769 [Abstract] [Full Text] [Related]
15. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Jo M, Thomas LE, Wheeler SE, Curry TE. Biol Reprod; 2004 Apr 27; 70(4):1024-32. PubMed ID: 14668206 [Abstract] [Full Text] [Related]
16. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN. J Pathol; 2000 Jul 27; 191(3):245-56. PubMed ID: 10878545 [Abstract] [Full Text] [Related]
18. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Lehti K, Lohi J, Valtanen H, Keski-Oja J. Biochem J; 1998 Sep 01; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492 [Abstract] [Full Text] [Related]
19. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. Cao J, Drews M, Lee HM, Conner C, Bahou WF, Zucker S. J Biol Chem; 1998 Dec 25; 273(52):34745-52. PubMed ID: 9856998 [Abstract] [Full Text] [Related]
20. Individual Timp deficiencies differentially impact pro-MMP-2 activation. English JL, Kassiri Z, Koskivirta I, Atkinson SJ, Di Grappa M, Soloway PD, Nagase H, Vuorio E, Murphy G, Khokha R. J Biol Chem; 2006 Apr 14; 281(15):10337-46. PubMed ID: 16469749 [Abstract] [Full Text] [Related] Page: [Next] [New Search]